Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psych Congress Network
A systematic review of 12 studies found that vortioxetine consistently improved depressive symptoms in adults aged 65 years and older with major depressive disorder, but evidence for cognitive benefits remained mixed and largely confined to selected cognitive domains.
Behavioral Health October 9th 2026
News Medical
Magnetoencephalography-based analysis of 263 patients with major depressive disorder identified five distinct brain connectivity profiles, each associated with differing symptom patterns, supporting the view that depression may encompass biologically heterogeneous subgroups rather than a single neurobiological condition.
The Journal of Infectious Diseases (JID)
Children exposed to maternal Tdap vaccination had lower pertussis toxin and diphtheria antibody concentrations at ages 3 and 4, but their responses matched controls after a preschool DTaP booster in this small Finnish follow-up.
Family Medicine/General Practice October 8th 2026
Journal of Magnetic Resonance Imaging (JMRI)
Among 29 CPAP-adherent men with severe obstructive sleep apnea, residual objective sleepiness was associated with white-matter diffusion differences, although the cross-sectional findings do not establish causality or support routine imaging.
Family Medicine/General Practice October 6th 2026
Medical News Today (MNT)
Experts reviewing available evidence suggest melatonin and magnesium may support sleep through different mechanisms, though benefits appear dependent on the underlying cause of sleep disturbance and overall evidence remains mixed, particularly for magnesium.
Behavioral Health October 1st 2026
A multicenter analysis of adults with biopsy-confirmed MASLD found that roughly one-quarter of cirrhosis cases developed before age 50, with type 2 diabetes and genetic susceptibility associated with earlier progression.
Endocrinology, Diabetes, Metabolism October 1st 2026